- Home
- RVPH vs TPST Comparison
RVPH vs TPST Comparison
Compare RVPH & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- TPST
- Stock Information
- Founded
- RVPH 2006
- TPST 2011
- Country
- RVPH United States
- TPST United States
- Employees
- RVPH N/A
- TPST N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- TPST Health Care
- Exchange
- RVPH Nasdaq
- TPST Nasdaq
- Market Cap
- RVPH 32.8M
- TPST 33.0M
- IPO Year
- RVPH N/A
- TPST N/A
- Fundamental
- Price
- RVPH $0.37
- TPST $7.08
- Analyst Decision
- RVPH Strong Buy
- TPST Hold
- Analyst Count
- RVPH 5
- TPST 3
- Target Price
- RVPH $9.00
- TPST $30.00
- AVG Volume (30 Days)
- RVPH 2.7M
- TPST 241.4K
- Earning Date
- RVPH 08-13-2025
- TPST 08-07-2025
- Dividend Yield
- RVPH N/A
- TPST N/A
- EPS Growth
- RVPH N/A
- TPST N/A
- EPS
- RVPH N/A
- TPST N/A
- Revenue
- RVPH N/A
- TPST N/A
- Revenue This Year
- RVPH N/A
- TPST N/A
- Revenue Next Year
- RVPH N/A
- TPST N/A
- P/E Ratio
- RVPH N/A
- TPST N/A
- Revenue Growth
- RVPH N/A
- TPST N/A
- 52 Week Low
- RVPH $0.30
- TPST $5.35
- 52 Week High
- RVPH $4.28
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- RVPH 30.92
- TPST 50.32
- Support Level
- RVPH $0.35
- TPST $6.73
- Resistance Level
- RVPH $0.83
- TPST $7.18
- Average True Range (ATR)
- RVPH 0.06
- TPST 0.29
- MACD
- RVPH -0.03
- TPST 0.00
- Stochastic Oscillator
- RVPH 12.62
- TPST 78.01
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.